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Cell-based therapies for regenerative medicine have been characterized by the low retention and integration of
injected cells into host structures. Cell immobilization in hydrogels for target cell delivery has been developed to
circumvent this issue. In this work mesenchymal stem cells isolated fromWistar rats bone marrow (rMSCs) were
immobilized in alginate beads fabricated using an innovative approach involving the gellification of the liquid
precursor droplets onto biomimetic superhydrophobic surfaces without the need of any precipitation bath. The
process occurred in mild conditions preventing the loss of cell viability. Furthermore, fibronectin (FN) was also
immobilized inside alginate beads with high efficiency in order to mimic the composition of the extracellular
matrix. This process occurred in a very fast way (around 5min), at room temperature, without aggressive
mechanical strengths or particle aggregation. The methodology employed allowed the production of alginate
beads exhibiting a homogenous rMSCs and FN distribution. Encapsulated rMSCs remained viable and were
released from the alginate for more than 20 days. In vivo assays were also performed, by implanting these
particles in a calvarial bone defect to evaluate their potential for bone tissue regeneration. Microcomputed
tomography and histological analysis results showed that this hybrid system accelerated bone regeneration
process. The methodology employed had a dual role by preventing cell and FN loss and avoiding any con-
tamination of the beads or exchange of molecules with the surrounding environment. In principle, the method
used for cell encapsulation could be extended to other systems aimed to be used in tissue regeneration strategies.
Introduction
Mesenchymal stem cells (MSCs) due to their multi-potent properties and high rate of proliferation have
been studied for regenerative medicine strategies.1,2 When
cultured under specific environments and appropriated
supplemented culture media, MSCs can differentiate into
lineages of mesenchymal tissues such as bone, cartilage, fat,
muscle, tendon, and marrow stroma.3
Hydrogels have been used as carrier’s materials to specifi-
cally deliver cells directly into damaged tissues, thus avoiding
cell loss through the blood stream.1,4–6 The highly hydrated
microenvironment and similar structure to the extracellular
matrix (ECM) of these carriers provide good permeability for
low molecular weight solutes, such as metabolites, nutrients,
or other bioactive molecules that can present biochemical,
cellular, and physical stimuli for cell differentiation, prolifer-
ation, and migration.7 The cells immobilized inside hydrogels
are physically isolated and consequently protected from the
deleterious outside environment.8–11 Although other shapes
can be employed, spheres have been the most explored due to
their large surface area, the ability to immobilize greater
amount of biologically active molecules, or cells per unit
volume12 and due to the possibility of application in most
complex systems such as cell-induced aggregates, cell carriers
for cell expansion, and organ printing.13
Several polysaccharides have been proposed as biomaterials
for tissue engineering and regenerative medicine.14 The vast
majority of them, such as alginate, are currently used in the
form of hydrogels to create structures with size features
ranging between 0.1 and 10mm.15 MSCs encapsulated in al-
ginate hydrogels have been reported in the literature for dif-
ferent applications, such as bone15 and cartilage regeneration,16
angiogenesis,17 and tumor treatment.18 The easy gelling and
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biocompatible properties of alginate hydrogels, obtained by
ionic crosslinking, have led to their study as cell transplanta-
tion vehicles for tissue regeneration.19 However, since alginate-
based hydrogels poorly bind serum proteins, different ECM
compounds such as fibronectin (FN),20 collagen,16,21 or RGD
sequences22,23 have been added to these polysaccharides in
order to offer adhesion sites to mammalian cells.
So far, the techniques used for cell immobilization inside
hydrogels required the mixing of gelling precursor with cells,
followed by gelation through a physical, chemical, or ionic
crosslinking. Several technologies have been proposed for
cell immobilization in hydrogel particles, and some of them
adopted from methodologies used in the pharmaceutical
industry24,25: emulsification, photolithography, micro-
fluidics, or coagulation baths using special dispensing sys-
tems of cell suspension in polymeric solutions. However, a
significant part of these methodologies imply the contact of
the gelling phase containing the cells or bioactive molecules
with another liquid phase, which may be responsible for cells
or molecules loss, due to their diffusion from the gel to the
supporting liquid. The uncontrolled entrance of solvents
may also lead to the contamination of the forming hydrogels,
which may compromise the viability of the cells entrapped
inside the matrix. In this work an innovative methodology
involving the use of superhydrophobic substrates26 was
employed to produce spherical hydrogels able to immobilize
cells and bioactive compounds with high efficiency. The
major advantages of this procedure include the use of mild
processing conditions, high encapsulation loading, lower
production costs, control of the particle size, and absence of
mechanical forces during particles formation. This method-
ology has already been validated for production of con-
trolled drug delivery systems.27 We hypothesize that the
method could be adapted to be used to encapsulate MSCs in
hydrogel spheres containing bioactive molecules for poste-
rior use in bone tissue engineering strategies. In vitro studies
were performed to analyze the effect of the immobilization
method on cell viability and also to evaluate cell differenti-
ation over time. After that, in vivo studies were also per-




Polystyrene (PS) from a grade for injection molding
was used in a granular shape for the preparation of the
superhydrophobic substrates. Tetrahydrofuran (THF,
99.9%) was purchased from Riedel de-Haen. 1H,1H,2H,2H-
perfluorodecyltriethoxysilane (PFDTS, 97%), low-viscosity
sodium alginate (ALG), FN from human plasma, Dulbecco’s
modified Eagle’s medium (DMEM-F12), trypsin, albumin
bovine serum (BSA, 96%), 4,6-diamidino-2-phenyindole, di-
lactate (DAPI), tetramethylrhodamine B isothiocyanate
(Phalloidin), and in vitro toxicology assay kit (lactate dehy-
drogenase [LDH] quantification) were purchased from Sigma-
Aldrich. Ethanol was purchased from Panreac. Calcium
chloride (CaCl2) was purchased from Merck. Fetal bovine
serum (FBS) was purchased from Biochrom AG. 3-[4,5-
dimethylthiazol-2-yl]-5-(3-carboxy-methoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt (MTS) and electron
coupling reagent (phenazine methosulfate; PMS) were pur-
chased from Promega. FN was labeled using Molecular
Probes’ Alexa Fluor 555 Protein Labeling kit and cells were
labeled with Hoechst 33342 and calcein acetoxymethyl ester
(calcein-AM) purchased from Invitrogen. Propidium iodide
(PI) was purchased from VWR. Hydrochloric acid solution was
purchased from Surgipath. All chemicals were used as received.
Methods
PS superhydrophobic surfaces. PS superhydrophobic
surfaces were prepared using a phase separation method as
described elsewhere.26,27 Briefly, a PS solution (70mg/mL) in
THF was prepared and then mixed with ethanol (2:1.3 v/v).
The mixture was dispensed onto smooth PS commercial
substrate, which was then immersed in ethanol for 1min and
dried with nitrogen flow. In order to increase the super-
hydrophobicity of obtained surfaces, the rough PS surfaces
were modified with PFDTS (1% v/v in ethanol) after argon
plasma treatment for 40 s at 30 W (Plasma Prep5; Gala In-
struments).
Preparation of the hydrogel particles. The beads were
produced using different ALG concentrations: 1%, 1.5%, and
2% (w/v). Five microliters of ALG solution were dispensed
on the PS superhydrophobic surface. The alginate hydrogel
beads were obtained on the surface after addition of 2 mL of
5% (w/v) CaCl2 solution on the top of each liquid sphere.
Stability of the alginate particles in culture medium. The
stability of the produced beads was analyzed through
quantification of calcium released from crosslinked alginate
beads immersed in cell culture medium. Five alginate beads
of each concentration were placed in 5mL of cell culture
medium (n = 3): DMEM-F12 supplemented with FBS (10%,
v/v), penicillin G (100U/cm3), streptomycin (100mg/cm3),
and amphotericin B (0.25 mg/cm3). The vials containing the
beads were kept at 37C. At pre-established periods of time,
aliquots of 1mL of the supernatant were taken out and re-
placed with equal volume of fresh cell culture medium to
maintain the volume constant during the release study. The
calcium concentration of the collected samples was mea-
sured using Coupled Plasma Spectrometry (ICP, JY 2000-2;
Horiba Jobin Yvon), after diluted 10 · in 1% HNO3 (v/v)
solution.
Cell culture and immobilization in alginate beads. MSCs
from Wistar rats femoral bone marrow28,29 were isolated as
previously described.30 Then, cells were seeded in T-flasks
with DMEM-F12 supplemented with FBS (10% v/v), peni-
cillin G (100U/cm3), streptomycin (100mg/cm3), and am-
photericin B (0.25 mg/cm3). rMSCs were kept in culture
inside an incubator at 37C with a 5% CO2 humidified at-
mosphere. After reached confluence, rMSCs were sub-
cultivated by a 3–5min incubation in 0.18% trypsin (1:250)
and 5mM ethylenediaminetetraacetic acid. Subsequently, the
rMSCs were centrifuged, resuspended in culture medium,
and then encapsulated in alginate beads. Cells were added to
1, 1.5, and 2wt% alginate solutions in order to obtain
*10,000 cells/bead. Some studies were carried out in the
presence of FN. In those cases, FN with a concentration of
250 mg/mL31 was added to alginate cell suspension. Five
microliters of cell suspension with or without FN was
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dispensed on the PS superhydrophobic surface (Fig. 1A). The
alginate hydrogel beads were obtained on the surface after
addition of 2mL of 5% (w/v) CaCl2 solution on the top of
each sphere (Fig. 1B). After that, the spheres were kept in
culture with 150 mL of cell culture medium (Fig. 1C).
The distribution of FN in alginate beads was observed by
fluorescent microscopy (Zeiss) using 250mg/mL of FN la-
beled with Alexa Fluor 555 dye following the protocol of
Molecular Probe’s Alexa Fluor 555 Protein Labeling kit.
Phalloidin and DAPI staining to visualize actin cytoskel-
eton and to label the DNA, respectively, were conducted as
outlined by the supplier’s protocol. Briefly, the particles were
washed with 0.15M of NaCl supplemented with 10mM of
CaCl2, fixed in freshly prepared 4% (v/v) of formaldehyde in
phosphate-buffered saline for 15min at room temperature
(RT), and washed extensively to remove all traces of the
fixative. The cells were then stained with 50 mg/mL fluores-
cent phalloidin for 45min at RT. DAPI labeling solution
(0.5 mg/mL) was incubated for 3min at RT. The particles
were washed again to remove remaining staining solutions
and visualized using a Zeiss LSM 710 confocal microscope
equipped with a 10 ·/0.5 dry Fluor objective (Carl Zeiss
SMT, Inc.).
Beads distribution size was investigated using a stereo
microscope (Stemi 1000 PG-HITECH; Zeiss). After being
prepared, alginate beads were immersed in cell culture me-
dia and observed under stereomicroscope immediately. The
mean particle size was calculated by analyzing the images
using the ImageJ software.
In vitro live/dead assay. rMSCs immobilized in alginate
beads were kept in culture, in a 96-well plate, with 150mL of
DMEM-F12 supplemented with FBS (10%, v/v), penicillin G
(100U/cm3), streptomycin (100 mg/cm3), and amphotericin B
(0.25 mg/cm3) and incubated at 37C, with a 5% CO2 hu-
midified atmosphere. After an incubation period of 24, 48,
and 72 h, cells viability was assessed through the reduction
of the MTS into a water-soluble formazan product.32 Briefly,
the medium of each well was removed and replaced with a
mixture of 100 mL of fresh culture medium and 20mL of
MTS/PMS reagent solution. Then, the beads were incubated
for 4 h at 37C. The absorbance was measured at 492 nm
using a microplate reader (Sanofi; Diagnostics Pauster).
Wells containing cells in the culture medium without being
immobilized in alginate were used as negative controls (K- ).
EtOH (96%) was added to wells with cells, to be used as a
positive control (K + ).32 Moreover, the amount of dead cells
was also quantified by the LDH assay, in 2% ALG + FN
particles due to the higher beads stability. LDH is released to
the medium through the damaged cell membrane and con-
vert a yellow tetrazolium salt into a red formazan dye, which
is quantified by reading its absorbance at 492 nm using a
microplate reader. The optical density is proportional to the
number of lysed cells.33 After 24, 48, and 72 h the well plates
containing the beads in culture were shaken briefly to ho-
mogenize the released LDH into the cell culture medium.
Then, 50 mL of the cell culture medium was transferred into a
fresh 96-well plate and 100 mL of LDH assay mixture was
added to each well.34 After 30–45min the enzymatic activity
was stopped by adding 7.5 mL of HCl and the absorbance
was measured. Wells containing cells in the culture without
being immobilized in alginate were used as negative control
and lysis solution was added to wells containing cells as a
positive control. The results obtained were expressed as the
mean– the standard error of the mean for at least three in-
dependent experiments.
Live/dead staining was also performed on 2% ALG + FN
particles. The beads were incubated for 15min at 37C and
immersed in 0.15M of NaCl complemented with 10mM of
CaCl2 where 2 mL of Calcein AM (1mg/mL) and 1mL of PI
(1mg/mL) were added. After incubation, the Calcein AM/
PI solution was removed and the beads were washed and
finally visualized in a Zeiss LSM 710 confocal microscope
with appropriated filters to detect green (live cells) and red
(dead cells).
Cell morphology: light microscopy, scanning electron mi-
croscopy, and fluorescent microscopy. rMSC morphology,
FIG. 1. Schematic representation of cell and protein immobilization in alginate hydrogels using polystyrene (PS) super-
hydrophobic substrates: 5mL drops of mesenchymal stem cells isolated fromWistar rats bone marrow (rMSCs)+fibronectin (FN)
suspension in a sodium alginate (ALG) solution were dispensed on PS superhydrophobic substrates (A). After, 2mL of CaCl2
was dispensed on the top of each drop to crosslink alginate (B). After 5min the spheres with rMSCs+FN immobilized
were collected (C) and in vitro (D) and in vivo (E) tests were performed. A bone defect was created in calvarial bone (E1) and
filled in with particles (E2) in order to evaluate the regeneration of the bone. Color images available online at www
.liebertpub.com/tea
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adhesion, and proliferation were firstly visualized using an
Olympus CX41 inverted light microscope, equipped with an
Olympus SP-500 UZ digital camera.
Scanning electron microscopy (SEM) was also used to ob-
serve the morphology of the rMSCs immobilized in the algi-
nate particles. To do so, samples were fixed overnight using
2.5% glutaraldehyde in water, at 4C. After that, they were
rinsed with distilled water and dehydrated in graded ethanol
of 70%, 80%, 90%, and 100% for 10min each. Finally, the
samples were mounted in supports using double-size adhe-
sive tape and coated with gold by using Emitech K550 sputter
coater. Samples were analyzed using a Hitachi S-2700 SEM.
Moreover, to visualize the rMSCs immobilized in alginate,
a Hoechst dye (H1399) was used to label cell nucleus. A
trihydrochloride trihydrate solution (2mg/mL) was added to
a cell pellet obtained by centrifugation and then resuspended
in culture media. After 30min in contact with Hoechst so-
lution, rMSCs were encapsulated in alginate in the same
conditions as previously described. rMSCs were visualized
after 0, 24, 48, and 72 h of incubation in a Zeiss AX10 mi-
croscope and analyzed with the Axio Vision Real 4.6 soft-
ware (Carl Zeiss SMT, Inc.).
Osteogenic induction. To induce osteogenic differentia-
tion, rMSCs immobilized in alginate beads were cultured in
osteogenic medium, which consisted on DMEM-F12 con-
taining FBS (10%, v/v), penicillin G (100U/cm3), strepto-
mycin (100 mg/cm3), amphotericin B (0.25 mg/cm3), and
supplemented with 0.1mM l-ascorbic acid 2-phosphate,
10mM beta-glycerol phosphate, and 100 nM dexametha-
sone.35 At 1, 7, 14, and 21 days postinduction, alginate beads
were fixed overnight in 2.5% glutaraldehyde in water, at 4C,
dehydrated in graded ethanol solutions, and finally embed-
ded in paraffin blocks. Sections of 4–5mm were stained with
alizarin red dye for the detection of calcium deposits. Mi-
croscope images were acquired with Zeiss Imager A.1.
In vivo assays. The in vivo experiments were performed
using 12 Wistar rats with an average weight of 200 g. Such
studies were done accordingly to the guidelines set forth in
the National Institutes of Health Guide for the care and use of
laboratory animals. Animals were anesthetized by intraper-
itoneal injection of ketamine (40mg/kg) and xylazine (5mg/
kg). Bone defects with *5mm diameter were made on cal-
varial bone and four beads with *10,000 rMSCs and FN
(250 mg/mL) were implanted inside it. The alginate concen-
tration with best results in vitro was selected to be tested in
animals (2% ALG). For that, three groups (n= 4) were cre-
ated: (1) controls with empty defects; (2) alginate beads just
with FN were implanted; and (3) an experimental group
where alginate beads with FN and immobilized rMSCs were
implanted. After its implantation into bone defects, animals
were maintained in individual cages with free access to
commercial rat food and water ad libitum. Then, animals
were euthanized after 4 weeks with an overdose of anes-
thetic.
Microcomputed tomography: Cranial bone samples ob-
tained at week 4 by necropsy were fixed in formaldehyde.
After dehydration, the samples were analyzed using a high-
resolution microcomputed tomography (mCT) Skyscan 1072
scanner (Skyscan). Scannings were performed in high-
resolution mode using a pixel size of 14.7 mm and integration
time of 1.7 s. The X-ray source was set at 51 kV of energy and
195 mA of current. For all samples, representative data sets
were transformed into binary using a dynamic threshold of
42–255. This data was used for morphometric analysis (CT
Analyzer v1.5.1.5; SkyScan). Three-dimensional (3D) virtual
models of calvarial bones were created, visualized, and
registered using the image-processing software (ANT 3D
creator v2.4; SkyScan).
Histology: Cranial bones samples used for mCT analysis were
then decalcified in a hydrochloric acid solution and embed-
ded in paraffin blocks. Furthermore, sample organs (brain,
heart, lung, liver, spleen, and kidney) were also collected,
fixed in formaldehyde, and embedded in paraffin blocks for
routine histological processing in order to check for any
morphological alteration. Sections of 4–5 mm were stained
with hematoxylin and eosin and finally visualized using a
light microscope (Zeiss Imager A.1).
Statistical analysis. Statistical analysis (GraphPad Prism;
GraphPad Software) concerning MTS and LDH assays was
performed using one-way analysis of variance following the
Table 1. Mean Size of the Produced Beads (n = 6)
Obtained Using Different Alginate Concentrations
Beads formulation Beads size (lm)
1% ALG 1930– 160
1.5% ALG 2030– 190
2% ALG 2180– 160
ALG, sodium alginate.
FIG. 2. Fluorescent microscopy
images of FN (250mg/mL) labeled
with Alexa Fluor 555 (A) and
rMCSs labeled with Phalloidin/
DAPI (B) inside 2% ALG beads.
DAPI, 4,6-diamidino-2-
phenylindole. Color images
available online at www
.liebertpub.com/tea
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Tukey’s post-hoc test with a significant set at p< 0.05. All the
results are presented as the mean – standard deviation.
Results and Discussion
rMSC and FN immobilization in alginate beads
Cell encapsulation is an important strategy to prevent the
escape and the elimination of the entrapped cells when im-
planted in damaged tissue sites.18 The most important ob-
jective of this work was the evaluation of the applicability of
superhydrophobic surfaces as a method to immobilize cells
(rMSCs previously isolated from Wistar rats) and unstable
molecules (as it is the case of proteins and glycoproteins,
such as FN) inside spherical hydrogels to be used in tissue
engineering purposes (see Fig. 1). The water-repellent prop-
erties of PS superhydrophobic surfaces allowed the produc-
tion of nearly spherical shape hydrophilic particles (Fig. 1D).
Different concentrations of alginate in the liquid precursors
were used (1%, 1.5%, and 2% w/v). The final diameter of
the obtained beads tended to increase with increasing algi-
nate concentration, despite the same volume of the precursor
solution was used (see Table 1). As an innovative method-
ology capable to immobilize mammalian cells and proteins,
superhydrophobic surfaces show several advantages when
compared with traditional techniques. For example, some of
those methodologies to produce polymeric particles have a
spread particle size distribution,36 which constitutes a
problem when a narrow range of sizes is required. As it is
possible to verify in the obtained results, the particles pro-
duced using superhydrophobic surfaces own a narrow size
distribution, highly controlled by the volume of the liquid
precursors dispensed over the substrates. This volume con-
trol could be interesting to produce particles with a specific
required size. In addition, the small range of particle size
obtained avoids additional steps for particle selection, saving
production time and costs. The absence of mechanical forces
that are sometimes responsible for cell damage and loss of
biological activity of molecules constitutes another advan-
tage of this methodology.
The dry environment where droplets harden into hydro-
gels avoids the particle aggregation and provide very high
encapsulation efficiency (almost 100%) because cells or bio-
active molecules are not in contact with surrounding fluid
media and they cannot migrate or diffuse outside the volume
FIG. 3. Cellular activity
quantified by MTS assay: (K- ),
negative control where cells were
cultivated in wells; (K + ), positive
control where the cells were dead
and rMSCs immobilized in three
different alginate concentrations
with and without FN. Each result is
the mean and respective standard
error of at least three independent
experiments.
FIG. 4. LDH quantification of
rMSCs immobilized in alginate
beads with FN in culture after 24,
48, and 72 h: (K- ) is the negative
control where cells were cultivated
in wells; (K + ) is the positive control
where the cells were dead. LDH,
lactate dehydrogenase.
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of the spherical objects. This is particularly useful because FN
molecules are water soluble,37 which is a bottleneck of the
encapsulation procedures previously described in litera-
ture,24 since water-soluble molecules are easily lost to the wet
media commonly used in those techniques. Moreover, this
characteristic is particularly important when expensive
molecules such as growth factors, or even genes, are desired
to be encapsulated. Compared with other immobilization
techniques, superhydrophobic surfaces allowed a very fast
particle production because the particles became completely
solid within the time of the cross-linking reaction, usually a
fast chemical or physical process.
The results obtained show (Fig. 2A, B) that FN molecules
and cells were homogenously distributed on the beads, in
agreement to our previous work, where BSA labeled with
fluorescein isothiocyanate was encapsulated in dextran/
poly(N-isopropylacrylomide (PNIPAAm) beads as a model
drug.27 The three studied formulations exhibited similar FN
and rMSC distribution (data not showed). To our knowledge,
the co-encapsulation of FN and rMSCs in alginate hydrogels
for bone regeneration applications was never studied before.
In vitro alginate cytotoxicity and rMSC
morphology studies
The synergistic effect of FN in cell viability was first
explored quantitatively through cytotoxicity evaluation.
Figure 3 shows MTS assay results and a significant differ-
ence between encapsulated cells and positive controls (dead
cells), both in the presence and in the absence of FN, for 24,
48, and 72 h was observed. This means that the material is
noncytotoxic and the rMSCs maintain their viability for at
least 3 days. The general decrease in cell viability observed
between 24 and 48 h for all alginate formulations may be
explained by the need of an accommodation period by the
rMSCs to adapt to new conditions. After this period the cell
viability remains constant.38
When compared the amount of viable cells immobilized
in the presence or absence of FN, it is possible to observe
that in the first 48 h of culture, there is a significant difference
between both conditions. This difference was attenuated after
72h, indicating that the effect of FN was more relevant in the
initial anchorage of the cells in the hydrogel structure. The
fraction of viable cells was higher in the presence of FN for all
alginate formulations (1%, 1.5%, and 2% ALG) (Fig. 3). It is
well known that FN is an ECM constituent with a relevant
role in regulation of cell adhesion, proliferation, and differ-
entiation,39 which are very important factors for osteogenesis
of human MSCs,21 as also that FN presence in the plasma
modulates the response of the body against new implanted
biomaterials constituting a good strategy to improve the
performance of biomedical devices.40 Having this into ac-
count, the entrapment of FN in alginate beads, beyond con-
tributing to increase cell viability should also improve the
acceptance of the studied system in vivo.
To further characterize the carrier’s biocompatibility and
corroborate the MTS results, LDH assay was also performed
in the particles with FN and the corresponding fraction of dead
cells is shown in Figure 4. LDH is a stable cytoplasmatic en-
zyme that is released to the extracellular media when the cy-
toplasmatic membrane is damaged being directly proportional
to the percentage of dead cells.33 Figure 4 shows that during at
least 72h the percentage of dead rMSCs encapsulated in algi-
nate were maintained around 20%–25%, which is similar to the
value obtained for the negative control (normal cell culture).
FIG. 5. Live/dead staining of rMSCs immobilized into 2% ALG +FN beads over 21 days in culture. Color images available
online at www.liebertpub.com/tea
FIG. 6. Optical microscopy images of alginate particles
loaded with rMSCs. Group A were beads composed by 1%
ALG after 72h in culture in presence (A1) and absence (A2) of
FN. The same order of images disposition was followed for the
other alginate beads concentration: in group B was 1.5% ALG
and group C 2% ALG. The white arrows show the cells re-
leased due to the slight particle disintegration. Scale bar 20mm.
Color images available online at www.liebertpub.com/tea
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Finally, the distribution of the live and dead rMSCs inside
the 2% ALG +FN (the most stable formulation) particles was
accessed by calcein-AM/PI staining for 21 days of culture.
As it is possible observe in Figure 5, the majority of the cells
were green which means that were live and significant dif-
ferences were not observed over time. The beads provided
good conditions for rMCS survival and representative con-
focal microscopy images are observed in Figure 5. Regarding
the fraction of viable cells inside our alginate beads, similar
results were previously obtained by Zhao et al.41 for human
umbilical cord stem cell encapsulated in alginate, where the
percentage of viable cells ranged from *90% to 70%, after 7
days of culture.
Figure 6 presents optical microscopy images of beads with
different alginate concentrations in the presence and absence
of FN after 72 h in culture. After 1 day the cells were seen
well confined in the volume of the beads. Over 3 days in
culture, rMSCs remained with their typically round shape
and were homogeneously distributed inside the alginate
beads. However, at this time point, it was possible to detect a
slight particle disintegration and the consequently cell re-
lease (white arrows in Fig. 6) principally in weaker beads
corresponding to the ones prepared with lower alginate
concentrations. The released rMSCs migrated from the par-
ticle core to the surface, adhered in the wells, and probably
the proliferation started. The referred continuous cell release
and proliferation was accessed and followed by optical mi-
croscopy for more 18 days in all alginate concentrations even
after beads transferring to new well plates (see images in Fig.
7). The 1% ALG beads released a higher number of rMSCs
when compared to that of 1.5% and 2% ALG, for the same
period. Such finding can be explained by the alginate particle
disintegration, which occurred at higher rate for low con-
centration alginate beads. Similar results were earlier re-
ported by Hunt et al.42 They studied the degradation of 2%
and 5% w/v alginate matrix with immobilized fibroblasts
under normal cell culture conditions where it was shown
that the alginate degradation process was not influenced by
FIG. 7. Part I. The alginate particles with rMSCs+ FN were cultured in a well plate for 9 days and the rMSC morphology
was accessed by optical microscopy: (A) correspond to 1% ALG, (B) to 1.5% ALG, and (C) to 2% ALG after 5 days (A1, B1,
C1) and 7 days (A2, B2, C2) in culture. Part II. When the released rMSCs reach the confluence in the surface of the well plate,
the particles were transferred for a new plate. 1% ALG beads were not transferred because were completely disintegrated
before day 9. The other alginate formulations were cultured for more days and the continuous rMSC release was observed at
day 14 (B3, C3) and 21 (B4, C4). Scale bar 20mm. Color images available online at www.liebertpub.com/tea
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the presence of fibroblasts and that lowering the alginate
concentration from 5% to 1% increased the rate of disinte-
gration. The degradation of the alginate beads structure
could be explained by crosslinked chain disintegration
caused by the replacement of calcium cations (responsible for
the crosslinking) by monovalent cations such as sodium or
potassium present in cell culture medium.43,44 This was
confirmed by the release calcium studies, in which calcium
was released from alginate beads for 24 h (Fig. 8). Moreover,
it was hypothesized by Drury et al.45 that ion exchange and
the reordering of the alginate chain occur within the first 7
days and stabilize thereafter. In our study the 1% alginate
beads disintegrates completely after 7 days in culture me-
dium, while 1.5% and 2% alginate beads (or fragments) re-
mained stable for more than 21 days. However, there was no
significant effect on the concentration of alginate and the
quantity of calcium ions released within this time period.
Moreover, calcium is an essential element and plays a key
role in skeletal mineralization. During the bone formation,
osteoblasts capture calcium from bloodstream (that has been
absorbed previously in the intestine or resulted from osteo-
clasts activity) and deposit it in an appropriate site in the
form of calcium phosphate complexes.46 Regarding this, it is
possible that the in situ calcium delivered may help the
mineralization process during bone defect regeneration.
Another important parameter is the number of the cells
immobilized inside the beads because studies reported that
cell density must be sufficiently high to provide cell contact
and consequently the proliferation.38 Based on that, about
10,000 cells were encapsulated in beads with *2mm. Other
studies reported the use of particles containing cells with
similar dimensions. Alginate beads with 3.6, 2.2, and 1mm
were produced for cell encapsulation and used as compo-
nents of calcium phosphate cements and polymer pastes.41
The purpose of these beads is that they could quickly de-
grade and release the cells throughout the entire scaffolds.
However, a considerable part of alginate beads produced so
far did not present fast degradable properties and cell release
FIG. 8. Cumulative release of calcium ions from alginate
beads (1%, 1.5%, and 2% ALG) crosslinked with CaCl2 after
immersion in cell culture medium. The calcium at 0 h cor-
responds to the amount content in cell culture medium.
Color images available online at www.liebertpub.com/tea
FIG. 9. Scanning electron microscopy micrographs of 2%
ALG +FN without rMSCs (A); with rMSCs immobilized (B),
after 48 h in culture. (C) Corresponds to fluorescent micros-
copy images of rMSCs stained with Hoechst 33342 imme-
diately after immobilization in 2% ALG +FN.
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was not observed. Zhou and Xu47 reported that it is desirable
to have beads with a fast degradation profile in order to
promote a quick stem cells release, differentiation, and con-
sequently enhance production of new tissue. Having this into
account, it was expected that the fast release of the rMSCs
over time and their adhesion into a defect site allowed a
continuous and faster regeneration of the damaged tissue.
Due to the higher stability of 2% ALG +FN beads, this
formulation was selected to pursue the studies.
The SEM analysis revealed that 2% ALG beads without
cells (Fig. 9A) present a smooth surface structure. The algi-
nate beads loaded with cells exhibit several protuberances
with almost 10 mm diameter, which may be caused by the
presence of rMSCs immobilized inside the hydrogel (Fig. 9B).
To complement this assay, the rMSC nuclei were stained and
the immobilized cells were observed through a fluorescent
microscope (Fig. 9C). The images showed that cells were
inside alginate hydrogels and even on surface having a
FIG. 10. Alizarin red staining of
2% ALG +FN + rMSCs after 1 (A1,
A2), 7 (B1, B2), 14 (C1, C2), and 21
days (D1, D2) in culture under
basal and osteogenic conditions.
Color images available online at
www.liebertpub.com/tea
CELLS AND PROTEINS IMMOBILIZATION USING SUPERHYDROPHOBIC SUBSTRATES 1183
typical round shape. These results corroborate those ob-
tained by SEM analysis.
Osteogenic differentiation assay
Bone regeneration is a complex physiologic process that
includes cell recruitment and proliferation of progenitor cells
followed by its differentiation along osteoblastic lineage,
osteoid formation (deposition of ECM components), and fi-
nally mineralization.48 The matrix mineralization consists in
calcium deposits.49 Alizarin red staining (Fig. 10), which is a
specific dye for calcium detection,50 showed a staining in-
crease in 2% ALG + FN + rMSCs from day 1 to 14 (Fig. 10A2,
C2) and especially between day 14 and 21 (Fig. 10C2, D2),
when the beads were cultured under osteogenic conditions.
The same beads formulation maintained under basal condi-
tions did not show any difference in the color of the staining
over time (Fig. 10A1, B1, C1, D1).
The high permeability of alginate beads allowed the cre-
ation of an enabling in vitro environment for differentiation
of encapsulated rMSCs. Similar results were previously ob-
tained by Abbah et al.51 using murine-derived adipose-tissue
stromal cells encapsulated in alginate for 21 days.
These results also demonstrate that the produced alginate
beads had appropriated diffusion characteristics to allow the
entrance of nutrients or other molecules that play an im-
portant role in rMSC viability and differentiation.
In vivo bone regeneration
Wistar rats were used to perform the in vivo studies in
order to evaluate the biocompatibility of the carriers with
immobilized rMSCs and also their capability in stimulating
the regeneration of a bone defect not affected by high
mechanical stresses. In all studied groups, no specific in-
flammation or reactive granulomas were observed in tissues
surrounded the site where alginate beads were implanted.
Furthermore, no pathological abnormalities were observed
in the brain, lung, liver, spleen, heart, and kidney samples.
Representative mCT reconstructions of ex vivo bone ex-
plants around the defect regions are shown in Figure 11, 4
weeks postimplantation. In the defects of the control group,
where no beads were implanted, is not observed bone tissue
growth (see Fig. 11-I). Otherwise, in the group II (Fig. 11-II)
where alginate beads loaded with FN were implanted, the
3D reconstructions show a lower level of bone infiltration
compared with group III (Fig. 11-III), where alginate beads
loaded with FN and rMSCs were implanted.
Histological analysis was performed in order to confirm
the previous described results and also to obtain comple-
mentary information related to host response and tissue/
cellular organization (see Fig. 12). The light microscopic ex-
amination of decalcified sections showed that in control
(group I) and group II, new bone tissue formation inside of
the defect was not observed; only fragments of periosteum
were present. However, neo bone tissue was formed cir-
cumferentially along the defects of group III and a significant
amount of new bone tissue was visualized in the central
areas. In addition, the histology results show an active
periosteum and osteoblasts deposition which formed circular
structures that give rise to circular pieces of bone tissue
(black arrows in Fig. 12-III) without connection to the border
of the defect. The presence of osteoclastic-like cells was not
visualized as also reactive or granulomatous inflammatory
reactions in the surround tissue and fibrous connective tissue
in the local where beads were implanted. This supports the
local and systemic histocompatibility of these beads. These
last results showed that the presence of cells induced the
FIG. 11. Microcomputed tomography analysis of calvaria defects in Wistar rats. Images show the endpoint result after 4
weeks of bone regeneration of empty defects (I) and upon implantation of 2% ALG beads (II) loaded with FN and (III)
loaded with FN and rMSCs.
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growth of higher amount of new bone tissue after 4 weeks.
Furthermore, the visualized deposition of osteoblasts (black
arrows in Fig. 12-III) could be correlated with the release of
rMSCs by alginate beads, which in turn had the appro-
priated diffusion properties to allow the differentiation of
rMSCs under osteogenic conditions. On the other hand, the
differentiated cells released or even the ones remained inside
the particles could have delivered key proteins (e.g., growth
factors),52,53 which recruited other cells to the damaged site
and consequently accelerate the tissue regeneration.
Lee et al.54 demonstrated that calcium crosslinked alginate
beads mineralized when injected subcutaneously or implanted
intramuscularly after 1–6 months during which bone-like ap-
atite deposits were found throughout the microparticles. This
information reinforce that alginate is a very interesting mate-
rial to induce biomineralization and also confirms its applica-
tion for regeneration of bone damaged tissue.
Taking into account these results, the immobilization of
rMSCs with a component of ECM, namely FN, in alginate
hydrogels using superhydrophobic surfaces constitute an
interesting strategy to obtain particles for cell encapsulation
and delivery and to improve tissue regeneration in a cheap,
fast, and efficient way.
Conclusion
The present work evaluated the efficiency of an innovative
methodology for the encapsulation of unstable bioactive
molecules and cell immobilization in hydrogel spheres to be
used in tissue engineering strategies. The use of super-
hydrophobic PS substrates allowed the production of bio-
compatible calcium crosslinked alginate beads with viable
rMSCs entrapped. This methodology avoided important
disadvantages exhibited by conventional encapsulation
techniques, such as mechanical forces, particles aggregation,
cell and bioactive molecules loss, and wet conditions.
The application of the hybrid alginate beads for bone re-
generation was evaluated under in vitro and in vivo condi-
tions, and the results showed that the synergy effect between
FN and rMSCs was crucial for bone regeneration. The ALG
beads have good permeability for nutrients and O2, which
provides to the cells optimal conditions to survive for at least
FIG. 12. Hematoxylin and eosin-
stained histological images of
calvaria defects at 4 weeks: empty
control group (I), defects filled with
beads loaded with FN (II), and
beads loaded with FN and rMSCs
(III). The black arrows represent the
deposition of osteoblasts and
formation of circular bone pieces.
CB, compact bone; NB, new bone;
P, periosteum. Scale bar 200mm.
Color images available online at
www.liebertpub.com/tea
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21 days. In addition, the encapsulation of the cells allowed
their fixation in a proper site of the damaged tissue, avoiding
the possibility of cells being removed by the blood stream.
Moreover, the rMSCs were released at the same time of
alginate degradation, constituting an advantage since it
allowed the continuous bone regeneration without cell loss.
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